Non-Orange Book Patents for Patent: 9,089,567
For Orange Book-listed
patents (shown in the main table above) generic applications
must certify that the listed patents are expired, invalid, or
will not be infringed by generic entry.
The non-Orange Book patents listed
below do not require formal certifications, so they do not
automatically impede generic entry. Instead, they represent
potential opportunities for branded firms to block generic
entry through patent infringment challenges.
||Estimated Patent Expiration
|8,680,105||Method of treating down's syndrome||► Subscribe|
|7,053,092||5-HT1a receptor subtype agonist||► Subscribe|
|8,722,680||Method of treating neurodegenerative diseases||► Subscribe|
|9,006,248||5-HT.sub.1A receptor subtype agonist||► Subscribe|
|8,642,600||Method of treating autism||► Subscribe|
|8,604,041||Method of treating panic disorder||► Subscribe|
|9,387,207||5-HT1A receptor subtype agonist||► Subscribe|
|8,623,874||Method of treating neurodegenerative diseases||► Subscribe|
|8,426,423||Method of treating Attention Deficit Hyper-Activity Disorder||► Subscribe|
|8,030,312||5-HT1A receptor subtype agonist||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.